Page 64 - Ruchika Chitravanshi

Covid-19 vaccines safe, healthcare workers have no reason to doubt: Govt

Healthcare workers must endorse the inoculation, declining will be matter of sadness: Government officials

380,000 vaccinated so far, no serious adverse events, says health ministry

Two deaths were reported in Uttar Pradesh and Karnataka, one not linked to jab, the other yet to be investigated

Low turnout for the shot as six states vaccinate 17,000 on Sunday

Many adoopt wait-and-watch approach as confidence about safety and efficacy of the jab is low

India vaccinates over 190,000 on first day of rollout; Co-Win causes delays

Health Ministry said that it had received complaints of the Co-WIN digital platform being slow

PM Modi kicks-off the Covid-19 vaccine drive, urges people to show patience

India's vaccination drive is based on principles of humanity, says the prime minister

Covid-19 vaccination drive begins today; all you need to know about it

Under the emergency use authorisation, the vaccine is only for those above 18 years of age

Health ministry takes stock of vaccine preparation, assures jabs are safe

Over 3,000 sites across the country ready to vaccinate 300,000 health workers on first day. Some 100 beneficiaries will be given jab at each session site

49 scientists, doctors throw their weight behind Covid-19 vaccines

The decision of Drugs Controller General of India to allow accelerated approval or the emergency use approval for Covaxin had become a contentious issue

Both Serum's Covishield, Bharat Bio's Covaxin vaccines cost same to Centre

People can't choose between Covishield & Covaxin, says govt; vaccine to take effect two weeks after the second dose

Covid-19 likely to bring a sharper focus on health care in upcoming Budget

CII has also called for tax incentives for new health care projects and import duty relief for lifesaving equipment.

From factory to front line, all roads lead to Covid-19 vaccine roll-out

According to sources, a contract may be signed between the government and the vaccine makers on Monday, and the first batch of vaccinations will be done using Serum Institute's (SII's) Covishield

PM Modi meet with CMs to kickstart mega Covid-19 vaccination drive

The government is in the final stages of due diligence to ink a supply deal with Serum Institute of India and Bharat Biotech, which have got approval for emergency use of their vaccines

MCA proposes pre-packaged insolvency resolution process for Covid defaults

The future phases would cover a default above Rs 1 crore, followed by Rs 1 to Rs 1 lakh

Dry run for Covid-19 vaccine: States raise software, broadband issues

On Thursday, Health Minister Harsh Vardhan held a virtual meeting with the health ministers of all states on preparation and protocol for the Friday dry run

Around 75% of elderly in India suffering from a chronic disease: Study

The survey found that more than one in 10 people aged 60 and above have 'probable major depression' in states including Madhya Pradesh, Uttar Pradesh, Delhi, Bihar and Goa

Govt clears air on Bharat Biotech's vaccine, says relied on safety data

Minutes of expert panel meeting made public

Covid-19 vaccine: I am not worried about the efficacy, says Jacob John

I would go for Bharat Biotech's Covaxin and not Covishield, and that is my personal judgment, the former head of Centre for Advanced Research in Virology at ICMR says

Serum, Bharat Biotech vaccines get restricted use approval from DCGI

While the Oxford-AstraZeneca vaccine made by Serum Institute here has 70.42% efficacy, Bharat Biotech's still does not have efficacy data as trials are underway in India

Controversy around Bharat Biotech's Covaxin approval without efficacy data

Bharat Biotech's Covaxin is based on a whole inactivated virus platform, an old technology which is used to make vaccines given to infants

India readies for mega Covid vaccine rollout; phase 1 targets 300 million

On priority list: Health care and frontline workers; those over 50; and below 50 with co-morbidities